Studies in Mice to Improve Efficacy/Safety of Paclitaxel/Docetaxel with an Anti-I
Studies in Mice to Improve Efficacy/Safety of Paclitaxel/Docetaxel with an Anti-I
批准号:
7910225
负责人:
WILLIAM A. GARLAND
金额:
$16.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2012-05-31
关键词:
Angiogenesis InhibitorsAnimalsApoptosisApoptoticBone MarrowCancer PatientCellsClinicalComplexDataDevelopmentDiagnostic Neoplasm StagingDifferentiation InducerDifferentiation InhibitorDifferentiation TherapyDoseDrug KineticsEndothelial CellsEnvironmentFamilyFetal DevelopmentFundingGene ProteinsGenesGoalsGrantHelix-Turn-Helix MotifsHumanImatinibInhibitor of Differentiation ProteinsLifeMalignant NeoplasmsMicrotubulesMusNeoplasm MetastasisNude MiceOutcomePaclitaxelPatientsPharmaceutical PreparationsPhasePhenotypePlayProtein BindingProteinsRegimenRelative (related person)RoleSafetyTaxane CompoundTherapeuticTherapeutic IndexTimeTumor BiologyXenograft procedureangiogenesisbasebevacizumabcytotoxiccytotoxicitydocetaxelimprovedinhibitor/antagonistmeetingsmigrationpre-clinicalprecursor cellpreventpublic health relevancerepairedresearch clinical testingresearch studyresponsesenescencesmall moleculetaxanetumortumor growth
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Inhibitor of differentiation (Id) genes and proteins play a significant role in tumor biology, and an anti-Id therapy in combination with a taxanes, a widely prescribed class of cytotoxic (paclitaxel/docetaxel, docetaxel or protein-bound paclitaxel) to treat cancer, is hypothesized to significantly improve the efficacy of the taxane without compromising safety while also providing additional anti-cancer activity. An effective Id1 inhibitor would potentially improve the efficacy of the taxanes by three distinct mechanisms: (i) preventing endothelial repair and thereby promoting the intrinsic anti-angiogenic effect of paclitaxel/docetaxel, (ii) lowering the anti-apoptotic environment of the tumor making it more susceptible to the cytotoxicity of paclitaxel/docetaxel and (iii) augmenting the cytotoxicity of paclitaxel/docetaxel by a direct anti-cancer effect. The goal of this proposal is to provide data to justify formal preclinical development and initial clinical evaluation of this therapeutic approach with an anti-Id1 small molecule. Experiments to be funded by the grant include xenograft studies in mice to establish the optimum dosing regimen for both the anti-Id agent and the taxanes.
PUBLIC HEALTH RELEVANCE: Anti-microtubule taxanes like paclitaxel and docetaxel are widely prescribed cytotoxics to treat cancer. An effective Id1 inhibitor would potentially improve the efficacy of taxanes by three distinct mechanisms: (i) preventing endothelial repair and thereby promoting the intrinsic anti-angiogenic effect of taxanes, (ii) lowering the anti-apoptotic environment of the tumor making it more susceptible to the cytotoxicity of the taxanes, and (iii) augmenting the cytotoxicity of the taxanes by a direct anti-cancer effect. The goal of this proposal is to provide data to justify formal preclinical development and initial clinical evaluation of this therapeutic approach using an anti-Id1 small molecule.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Suppressors of kRAS Activity Discovered Using a Fruit Fly-based In-vivo Screen
-
批准号:9335553
-
项目类别:
-
资助金额:$104.37万
-
财政年份:2014
-
负责人:WILLIAM A. GARLAND
-
依托单位:
Screening with D. melanogaster to Discover Inhibitors G12V Mutated kRAS
-
批准号:8781928
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2014
-
负责人:WILLIAM A. GARLAND
-
依托单位:
Anchored Antioxidants to Provide Increased Protective Effect
-
批准号:7926453
-
项目类别:
-
资助金额:$19.95万
-
财政年份:2010
-
负责人:WILLIAM A. GARLAND
-
依托单位:
NRTS AS THERAPEUTICS FOR DEMENTIA ASSOCIATED WITH HIV
-
批准号:2714277
-
项目类别:
-
资助金额:$35.52万
-
财政年份:1996
-
负责人:WILLIAM A. GARLAND
-
依托单位:
NRTS AS THERAPEUTICS FOR INFLAMMATORY BOWEL DISEASE
-
批准号:2790352
-
项目类别:
-
资助金额:$36.57万
-
财政年份:1996
-
负责人:WILLIAM A. GARLAND
-
依托单位:
NRTS AS THERAPEUTICS FOR INFLAMMATORY BOWEL DISEASE
-
批准号:6177655
-
项目类别:
-
资助金额:$37.12万
-
财政年份:1996
-
负责人:WILLIAM A. GARLAND
-
依托单位:
NRTS AS THERAPEUTIC FOR DEMENTIA ASSOCIATED WITH HIV
-
批准号:2035461
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1996
-
负责人:WILLIAM A. GARLAND
-
依托单位:
NRTS AS TREATMENT FOR INFLAMMATORY BOWEL DISEASE
-
批准号:2152798
-
项目类别:
-
资助金额:$9.73万
-
财政年份:1996
-
负责人:WILLIAM A. GARLAND
-
依托单位:
NRTS AS THERAPEUTICS FOR AMYOTROPHIC LATERAL SCLEROSIS
-
批准号:2273854
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1995
-
负责人:WILLIAM A. GARLAND
-
依托单位:
海外基金